Skip to content

Author

H. M. Chaparro-Solano

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Disentangling amantadine response variability in levodopa related dyskinesias: Role of clinical and genetic factors.

BACKGROUND Amantadine is the most commonly used pharmacologic treatment for levodopa-related dyskinesias (LRD), yet its efficacy and tolerability vary substantially, challenging clinical decision-making. OBJECTIVE To explore clinical, demographic, and genetic factors associated with variability in amantadine treatmen...

H. M. Chaparro-Solano, L. Saadatpour, J. Yu et al. · 0 citations
Open access Oct 2026

TMEM106B analysis in diverse cohorts suggests no association with Parkinson’s disease risk

Recent evidence suggests that TMEM106B expression is reduced in the brains of patients with Parkinson's disease (PD). However, an association between rare genetic variants in TMEM106B and PD risk has not been previously established. In this work, we investigated the association between rare TMEM106B variants and PD ris...

H. M. Chaparro-Solano, S. Kanagasingam, Z. Gan-or et al. · 0 citations
Open access Sep 2026

Genomic Landscape of Early-Onset and Familial Latin American Parkinson’s Patients

By expanding the reported spectrum of disease-associated variants in a Latin American population, this work identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin Am...

E. Waldo, H. M. Chaparro-Solano, M. Isayan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.